With an upgraded reactor for its exclusive extraction process, the company can now generate more than 300,000 litres of its unique, Omega-3 flaxseed oil product each year, it told investors on Wednesday.
READ: LeanLife Health sells surplus production equipment as it continues to grow its Omega-3 focused business
It comes after last month's announcement that it had sold some equipment it bought last year, which was surplus to requirements.
"With this new equipment, along with some relatively inexpensive future additions and automation, LeanLife will be able to increase its production capacity to over 20,000 litres per week or 1,000,000 litres per year," the company said.
"This puts the company in a position to scale up its efficient process to even higher-volumes as customer demand increases."
Moreover, the new reactor was used to produce samples for LeanLife’s growing international network of sales agents who are focused on securing over C$1 million of new customer contracts in 2020, it added.
Notably, it has reduced both labour and production costs, thereby lifting the profit margin, it added.
Fortified food ingredient
LeanLife Health's products are long-term, shelf-stable extractions from flax seed - a plentiful plant-based source of Omega-3, which makes them a fortified food ingredient.
The products are available in oil, emulsion and powder forms and can be used as food additives or as nutraceuticals.
They have been used to make bread, noodles, cheese, yogurt, juice and milk products for the European market.
The global Omega-3 market reached US$33 billion in 2016 and is expected to reach upwards of US$57 billion by 2025, according to a report by Grand View Research Inc.
Contact the author at [email protected]